Hapi_ Dr. Khaled Abdel Ghaffar, Minister of Health and Population, received today, Thursday, representatives of Sanofi to discuss ways to enhance cooperation and expand investment opportunities in the health sector, at the Ministry's headquarters in the New Capital.
The delegation included Richard Alex, M&A Project Manager at Sanofi France; Philip Haas, Chairman of East Pharma; and Maged El-Sayed, Head of Market Access and Government Affairs at Sanofi Egypt and Africa.
The Minister welcomed the attendees, expressing his appreciation for the cooperation and coordination in a number of health files of mutual interest, and emphasizing that consolidating cooperation ties and opening new horizons for investment contribute to supporting the health system and improving the level of services provided to citizens.
Dr. Hossam Abdel Ghaffar, the official spokesperson for the Ministry, stated that the Minister affirmed the Egyptian government's keenness to increase investment rates in the health sector and enhance partnership with the private sector, supporting the development of the system and elevating the quality of services in accordance with international standards.
He added that the meeting addressed discussing available investment opportunities in the Egyptian market and ways to expand in the pharmaceutical sector, particularly in the field of pharmaceutical manufacturing, to meet the needs of the local market and support increased production, in light of the large population base that provides wide local demand.
He continued that the two sides discussed Egypt's potentials to enhance its position as a regional hub for pharmaceutical manufacturing, foremost of which is its strategic geographical position as a main gateway for exporting to African markets, alongside the availability of qualified human cadres, which enhances the prospects for expanding the manufacturing of pharmaceuticals and vaccines.
At the close of the meeting, the Minister emphasized the importance of continuing to discuss joint cooperation opportunities in the field of pharmaceutical manufacturing and exploring new investment areas in the health sector, contributing to supporting the pharmaceutical industry in Egypt and meeting the health needs of citizens.
